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The host range of the murine coronavirus (MHV) is limited to susceptible mice and murine cell lines by interactions of the spike
glycoprotein (S) with its receptor, mCEACAM1a. We identified five residues in S (S33, L79, T82, Y162 and K183) that are conserved in the
receptor-binding domain of MHV strains, but not in related coronaviruses. We used targeted RNA recombination to generate isogenic viruses
that differ from MHV-A59 by amino acid substitutions in S. Viruses with S33R and K183R substitutions had wild type growth, while L79A/
T82A viruses formed small plaques. Viruses with S33G, L79M/T82M or K183G substitutions could only be recovered from cells that over-
expressed a mutant mCEACAM1a. Viruses with Y162H or Y162Q substitutions were never recovered, while Y162A viruses formed minute
plaques. However, viruses with Y162F substitutions had wild type growth, suggesting that Y162 may comprise part of a hydrophobic domain
that contacts the MHV-binding site of mCEACAM1a.
D 2005 Elsevier Inc. All rights reserved.
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Viruses of the Coronaviridae family form three distinct
antigenic and phylogenetic groups (Lai and Holmes, 2001).
Coronaviruses in group II infect mice, rats, cattle or humans,
as well as several other host species. Only one cellular
glycoprotein has been identified as a receptor for a group II
coronavirus. The murine coronavirus [murine hepatitis virus
(MHV)] utilizes as receptors murine carcinoembryonic
antigen cell adhesion molecule 1a (mCEACAM1a) and
related murine glycoproteins in the CEA family of
glycoproteins in the immunoglobulin (Ig) superfamily
(Dveksler et al., 1993a, 1993b; Yokomori and Lai, 1992).
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Research Center, 1400 Jackson Street, Denver, CO, USA.hemagglutinin esterase (HE) glycoprotein that binds to 9-O-
acetylated neuraminic acid, but the A59 strain of MHV
(MHV-A59) does not express HE (Yokomori et al., 1991).
Thus, MHV-A59 infection of susceptible mice and murine
cell lines depends solely on interactions of the viral spike
glycoprotein (S) with mCEACAM1a and related murine
glycoproteins (Hemmila et al., 2004).
Although the variety of hosts infected by coronaviruses
illustrates that these viruses can emerge in a new host
species, the mechanisms required for the introduction of a
coronavirus into a new host are not well understood. The
interaction of the viral spike glycoprotein with a specific
cellular glycoprotein receptor is a major determinant of
coronavirus host range. Cell lines from host species that are
normally resistant to MHV, porcine coronavirus [trans-
missible gastroenteritis virus (TGEV)] or human coronavi-
rus strain 229E (HCoV-229E) are rendered susceptible to
infection by transfection with cDNA encoding the specific
coronavirus receptors mCEACAM1a, porcine aminopepti-
dase N (pAPN) or human APN (hAPN), respectively05) 98–110
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1992). The 180-kDa S of MHV is a type I viral fusion
protein that mediates both receptor binding and membrane
fusion activities (Bosch et al., 2003; Gallagher and
Buchmeier, 2001). S of MHV-A59 is post-translationally
cleaved by a cellular protease into 90 kDa S1 and S2
proteins that remain non-covalently associated on the viral
envelope. Variations in the amino acid (aa) sequence of S1
of MHV strains are associated with differences in tissue
tropism and pathogenesis (Leparc-Goffart et al., 1998;
Phillips et al., 2001). The membrane-anchored S2 contains
a coiled-coil domain that is likely associated with membrane
fusion and is more highly conserved among MHV strains
than S1 (Bosch et al., 2003).
MHV and the blocking anti-mCEACAM1a monoclonal
antibody, MAb-CC1, bind to the amino (N)-terminal Ig-like
domain of mCEACAM1a (Dveksler et al., 1993a, 1993b).
Binding of the N-terminal domain of soluble mCEACAM1a
to S1 on MHV virions at 37 8C induces conformational
changes in S1 and S2 proteins, and neutralizes virus
(Gallagher, 1997; Lewicki and Gallagher, 2002; Matsuyama
and Taguchi, 2002; Miura et al., 2004; Zelus et al., 1998).
Incubation of purified MHV-A59 virions with soluble
mCEACAM1a at neutral pH, or without receptor at pH
8.0, triggers major conformational changes in S2 (Zelus et
al., 2003). These conformational changes may expose a
hydrophobic domain in S that allows virus to bind
liposomes and presumably initiates fusion of the viral
envelope with host cell membranes, as well as cell-to-cell
fusion. Mutational analyses of determinants in mCEA-
CAM1a that alter MHV binding and entry implicated
residues in the predicted CCV loop and the CV h sheet in
the N-terminal domain of mCEACAM1a (Rao et al., 1997;
Wessner et al., 1998). The predicted CCV loop was also
shown by mutational analyses to be critical for recognition
of human CEACAM1 by bacterial pathogens such as
Neisseria, as well as for homophilic cell adhesion (Bos et
al., 1999; Virji et al., 1999; Watt et al., 2001). The crystal
structure of mCEACAM1a[1,4] showed that the CCV loop
has a convoluted conformation unlike other Ig superfamily
glycoproteins (Tan et al., 2002). The side chain of an
isoleucine at residue 41 (I41) projects upwards away from
the membrane and was predicted to play an important role in
mCEACAM1a recognition by MHV S proteins.
The structural characterization of S is limited to fusion
cores of S2 proteins of MHV and severe acute respiratory
syndrome coronavirus (SARS-CoV) (Bosch et al., 2003;
Liu et al., 2004; Tripet et al., 2004; Xu et al., 2004).
Domains of S that are responsible for receptor binding have
been identified for several coronaviruses. Aa 417–547 of S
of HCoV-229E comprise a minimal receptor binding
domain (RBD) for hAPN expressed on cell membranes
(Bonavia et al., 2003; Breslin et al., 2003), while aa 1–330
of S of MHV (S330) comprise the minimal domain for
binding to soluble mCEACAM1a in vitro and initiating
infection via anchored mCEACAM1a (Kubo et al., 1994;Tsai et al., 2003). Aa 318–510 of S of SARS-CoV comprise
a minimal domain for binding to angiotensin converting
enzyme 2 (ACE2) in vitro (Babcock et al., 2004; Li et al.,
2003; Wong et al., 2004; Xiao et al., 2003). Recently, we
demonstrated that the N-terminal region of S1 containing 21
aa substitutions and a 7-aa insert derived from MHV/BHK,
a virus variant generated during persistent MHV-A59
infection of murine cells, is sufficient to extend the host
range of MHV-A59 in vitro (Sawicki et al., 1995; Schickli
et al., 1997, 2004; Thackray and Holmes, 2004). Residues
critical for receptor utilization and host specificity have not
been identified for most coronaviruses, although several
residues that play a role in the interactions of the MHV S
protein with mCEACAM1a or of the SARS-CoV S protein
with ACE2 have been identified (Saeki et al., 1997; Suzuki
and Taguchi, 1996; Wong et al., 2004). With the emergence
of SARS-CoV in humans and the search for effective drug-
based interventions for coronavirus infection, the need to
identify residues critical for the interactions of coronavi-
ruses with their cellular receptors is greater than ever.
We compared the N-terminal 330 aa of S proteins of
seven MHV strains with the N-termini of S proteins of the
extended host range variant MHV/BHK, as well as related
group II coronaviruses of rats, cattle and humans. We
identified five residues that are highly conserved in S330 of
all MHV strains and MHV/BHK, but are not found in S330
of rat, bovine or human coronaviruses of group II. To
examine the roles of these residues in the receptor
specificity of S, we used targeted RNA recombination
(TRR) to generate isogenic viruses that differ from MHV-
A59 at one or two aa in the RBD of S. We showed that
Y162 is critical for the recovery of MHV-A59 from cells
expressing mCEACAM1a. We also found that certain aa
substitutions at S33, L79, T82 or K183 can inhibit the
recovery of MHV-A59 from murine cells.Results
Generation of recombinant viruses
To identify residues that are involved in the receptor
specificity of the S glycoprotein of MHV, we compared the
N-terminal 330 aa of S proteins of seven MHV strains with
the N-termini of S proteins of related coronaviruses of rats,
cattle and humans. We identified four residues, S33, T82,
Y162 and K183, that are conserved in S330 of all MHV
strains, but not in the corresponding domains of rat, bovine
and human coronaviruses in group II (Fig. 1A). Another
residue, L79, is conserved in S330 of all MHV strains,
except MHV 2, but not in S330 of rat, bovine or human
group II coronaviruses. These five residues are also
conserved in the extended host range variant MHV/BHK
that infects a wide range of non-murine cell lines while
maintaining the ability to infect murine cells (Schickli et al.,
2004; Thackray and Holmes, 2004). To examine the roles of
Fig. 1. (A) Residues conserved in spike glycoproteins of murine coronaviruses. Four residues (black diamonds) are conserved in the N-terminal 330 aa of S
proteins of MHV strains (MHV-A59, MHV-JHM, MHV-1, MHV-2, MHV-3, MHV-S and MHV-U) and an extended host range variant of MHV-A59 (MHV/
BHK), but not in the N-termini of S proteins of related rat (RCoV), bovine (BCoV) and human (HCoV-OC43) coronaviruses in group II. Two residues (grey
diamonds) conserved in S proteins of murine, rat, bovine and human coronaviruses in group II are also indicated. (B) Composition of S construct used to
introduce mutations into MHV-A59 using targeted RNA recombination. Mutations were engineered into the S/pBC SK+ plasmid and subcloned into the
pMH54 plasmid. The minimal receptor binding domain (RBD) for murine CEACAM1a is shaded in gray.
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to introduce single aa substitutions at S33, Y162 or K183
and double aa substitutions at L79 and T82 into the genome
of MHV-A59. The aa substitutions were chosen to reflect
residues found in rat, bovine or human group II coronavi-
ruses, a conservative Y to F substitution, or neutral alanine
substitutions (Fig. 1A). Although aa substitutions at T62 or
L65 in S330 of MHV-JHM were previously associated with
reduced mCEACAM1a binding (Saeki et al., 1997; Suzuki
and Taguchi, 1996), we observed that T62 and L65 were
conserved in S330 of all MHV strains, as well as S330 of
related rat, bovine and human coronaviruses (Fig. 1A). To
examine the roles of these residues in the receptor
specificity of S in the context of infectious isogenic viruses,
we used targeted RNA recombination (TRR) to introduce aa
substitutions at T62 or L65 into the genome of MHV-A59.
The aa substitutions were chosen to reflect substitutions
made previously, S and H for T62 and L65, respectively,
(Saeki et al., 1997; Suzuki and Taguchi, 1996) or neutral
alanine substitutions.
Donor RNAs, transcribed in vitro from pMH54 con-
structs, were transfected into feline (Fcwf) cells that had
been inoculated with the chimeric helper virus fMHV (Kuo
et al., 2000). RNA recombination occurs between fMHV,
which contains a chimeric S gene with the ectodomain of
feline infectious peritonitis virus and the rest of the MHV-
A59 genome, and the pMH54 donor RNA containing the 3V-
most 7.4 kb of the MHV-A59 genome (Kuo et al., 2000).
The infected and transfected Fcwf cells were immediately
overlaid onto monolayers of murine 17 Cl 1 cells to select
for isogenic recombinant viruses that had gained the ability
to infect murine cells. For each mutant pMH54 construct,three recombinant viruses (A, B and C) were independently
recovered and plaque-purified to control for adventitious
mutations that might arise during TRR. In addition, in every
experiment, pMH54 RNA encoding wild-type MHV-A59 S
protein was used to reconstitute wild-type MHV-A59 virus
(SA59) in triplicate.
Extensive cytopathic effects (CPE) were seen at 48 h in
17 Cl 1 cell monolayers overlaid with fMHV-inoculated
Fcwf cells transfected with pMH54 RNA or pMH54 RNAs
encoding S33R, T62S, T62A, Y162F or K183R substitu-
tions. In contrast, 17 Cl 1 cell monolayers overlaid with
fMHV-inoculated Fcwf cells transfected with pMH54 RNAs
encoding L65H, L65A or L79A/T82A substitutions
exhibited less CPE at 48–72 h, while 17 Cl 1 cell
monolayers overlaid with fMHV-inoculated Fcwf cells
mock-transfected or transfected with pMH54 RNAs encod-
ing S33G, L79M/T82M, Y162H, Y162Q, Y162A or
K183G substitutions exhibited no detectable CPE even
after 72 h.
Recovery of recombinant viruses from cells that express
murine CEACAM1a
Most of the recombinant viruses formed uniform plaques
on 17 Cl 1 monolayers, although recombinant viruses
derived from the L65H or L65A constructs formed clear and
opaque plaques (data not shown). Several mutant viruses
were never recovered from 17 Cl 1 cell monolayers (Table
1), either because the mutant S proteins interacted ineffi-
ciently with mCEACAM1a or because the mutant S proteins
were inefficiently incorporated into MHV virions. TRR
using fMHV-inoculated Fcwf cells transfected with pMH54
Table 1
Recovery of viruses from cells expressing mCEACAM1a
Virus Murine 17 Cl 1a Hamster BHK +
mCEACAM1a(I41R)b
MHV-A59 + ND
SA59 + +
S33R + ND
S33G  +
T62S + ND
T62A + ND
L65H + ND
L65A + ND
L79M/T82M  +
L79A/T82A + ND
Y162H  
Y162Q  
Y162A  
Y162F + ND
K183R + ND
K183G  +
(ND) = not done.
a Determined by neutral red staining and immunoperoxidase labeling of
viral N protein in 17 Cl 1 cell monolayers.
b Determined by neutral red staining and immunoperoxidase labeling of
viral N protein in 17 Cl 1 and BHK + mCEACAM1a (I41R) cell
monolayers.
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Y162A or K183G substitutions was repeated several times,
but none of these mutant viruses could be recovered from 17
Cl 1 cell monolayers.
In order to isolate these crippled viruses with mutant S
proteins, we used hamster (BHK) cells stably expressing
mCEACAM1a[1,4] containing an I41R substitution [BHK +
mCEACAM1a(I41R)]. These cells expressed 10-fold more
receptor than either 17 Cl 1 cells or BHK cells stably
expressing wild type mCEACAM1a[1,4], as measured by
flow cytometry using anti-mCEACAM1a MAb CC1 (data
not shown). BHK + mCEACAM1a(I41R) cell monolayers
overlaid with fMHV-inoculated Fcwf cells transfected with
pMH54 or pMH54 RNAs encoding S33R, L79M/T82M or
K183G substitutions exhibited extensive CPE at 48 h, while
no CPE was detected even at 72 h in cells transfected with
pMH54 RNAs encoding Y162H, Y162Q or Y162A sub-
stitutions. All three recombinant viruses derived from each of
the SA59, S33G, L79M/T82M or K183G constructs formed
uniform plaques on BHK + mCEACAM1a(I41R) cell
monolayers, as well as on 17 Cl 1 cells (data not shown).
We do not know whether the recovery of the S33G, L79M/
T82M or K183R viruses from BHK + mCEACAM1a(I41R)
cells was facilitated by the high level of receptor expression in
these cells or the I41R substitution in the N-terminal domain
of mCEACAM1a. However, the recovery phenotypes and
plaque morphologies shared by the three replicates of each
mutant virus suggest that the engineered mutations in S330
were responsible for the observed phenotypes of these
viruses. We further characterized the S33G, L79M/T82M
and K183G viruses that were subsequently plaque-purified
and propagated in 17 Cl 1 cells.Spread of EGFP recombinant viruses in cells expressing
mCEACAM1a
Viruses derived from the Y162H, Y162Q and Y162A
constructs were not recovered from either 17 Cl 1 or
BHK + mCEACAM1a(I41R) cell monolayers (Table 1).
TRR using fMHV-inoculated Fcwf cells transfected with
pMH54 RNAs encoding Y162H, Y162Q or Y162A
substitutions was repeated several times, but these mutant
viruses were not recovered from BHK + mCEACA-
M1a(I41R) cell monolayers. To examine the infectivity
and spread of these crippled viruses with mutant S
proteins immediately after TRR, we used a pMH54-EGFP
plasmid that contains the enhanced green fluorescent
protein (EGFP) gene in place of gene 4 (Das Sarma et
al., 2002). Gene 4 is not essential for replication of MHV-
A59, since MHV-A59 EGFP has wild type growth in
vitro and in vivo. Donor RNAs, transcribed in vitro from
mutant pMH54-EGFP constructs, were transfected into
Fcwf cells that had been inoculated with the chimeric
helper virus fMHV (Kuo et al., 2000). The infected and
transfected Fcwf cells were immediately overlaid in
duplicate onto monolayers of 17 Cl 1 or BHK +
mCEACAM1a(I41R) cells. For each mutant pMH54-
EGFP construct, two recombinant viruses (A and B)
were independently recovered. In addition, wild-type
pMH54-EGFP RNA was used to reconstitute wild type
MHV-A59 EGFP virus (SA59-EGFP) in duplicate.
Nearly all of the 17 Cl 1 or BHK + mCEACAM1a(I41R)
cells overlaid with fMHV-inoculated Fcwf cells transfected
with pMH54-EGFP or pMH54-EGFP encoding a Y162F
substitution exhibited extensive CPE and strong EGFP
expression at 48 h (Fig. 2). In contrast, less than 0.01% of
the 17 Cl 1 or BHK + mCEACAM1a(I41R) cells overlaid
with fMHV-inoculated Fcwf cells transfected with pMH54-
EGFP encoding Y162H, Y162Q or Y162A substitutions
exhibited CPE and EGFP expression at 48 h. Although
Y162A-EGFP viruses induced several large syncytia in
BHK + mCEACAM1a(I41R) cells, the number of cells
infected by Y162A-EGFP viruses decreased between 24 and
48 h (Fig. 2). These results suggested that H, Q or A
substitutions for Y162 that reflect residues found at
corresponding residues in S330 of rat, bovine or human
coronaviruses in group II altered the interaction of MHV-
A59 virions with mCEACAM1a.
The detection of the mutant EGFP viruses in 17 Cl 1 cells
prompted us to examine the plaque forming ability of the
Y162H, Y162Q and Y162A-EGFP viruses on 17 Cl 1 cell
monolayers. Both replicates of the SA59, Y162A and
Y162F-EGFP viruses formed plaques that exhibited EGFP
expression in 17 Cl 1 cells monolayers (data not shown).
Both of the Y162F-EGFP viruses formed large, 4–5 mm
plaques on 17 Cl 1 cell monolayers like MHV-A59 (Fig. 3).
However, both of the Y162A-EGFP viruses formed minute,
0.5 mm plaques that were difficult to visualize with neutral
red staining, but were readily apparent using immunoper-
Fig. 2. Growth of EGFP viruses in murine 17 Cl 1 or hamster BHK + mCEACAM1a(I41R) cells. EGFP was visualized in cell monolayers overlaid with
fMHV-inoculated Fcwf cells transfected with wild type (SA59) or mutant pMH54-EGFP RNAs. None of the 17 Cl 1 or BHK + mCEACAM1a(I41R) cells
overlaid with mock-inoculated Fcwf cells transfected with wild type or mutant pMH54-EGFP RNAs exhibited EGFP expression. Magnification, 200.
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cell monolayers (Fig. 3). The yields of the Y162A-EGFP
viruses from 17 Cl 1 cells were 10,000-fold lower than those
of the SA59 and Y162F-EGFP viruses. Consequently, the
EGFP viruses were not studied further.
Sequence analysis of recombinant viruses
To identify mutant viruses that were free of adventi-
tious mutations in the S gene, we sequenced the S genes
of plaque-purified recombinant viruses derived from
mutant pMH54 constructs. Point mutations were found
in the S genes of the SA59 A, S33G A and B, L65H Aand B, L65A A and B and L79A/T82A A viruses (Table
2). The S genes of the SA59 B, S33R A, S33G C, T62S
A, T62A A, L65H C, L65A C, L79M/T82M A, L79A/
T82A B and K183G A viruses were free of adventitious
mutations, while the S genes of the Y162F A and K183R
A viruses had only non-coding adventitious mutations
(Table 2). The lack of adventitious mutations in the S
genes of the S33G C, L79M/T82M A, B, and C, and
K183G A, B, and C viruses suggests that second-site
mutations in the S gene were not responsible for the
observed ability of these viruses to form plaques on 17 Cl
1 cells after their recovery from BHK + mCEACA-
M1a(I41R) cell monolayers.
Fig. 3. Plaque morphologies of EGFP viruses on murine 17 Cl 1 cell
monolayers. Plaques of the SA59, Y162F and Y162A-EGFP viruses were
visualized at 72 h post-inoculation (p.i.) by neutral red staining (neutral red)
or immunoperoxidase labeling of viral nucleocapsid protein (N antigen) in
cell monolayers. Plaques formed by the Y162A-EGFP virus are indicated
by black arrows.
Table 2
Adventitious mutations found in the S genes of recombinant virusesa
Virus Mutationsb (nt) Substitutions (aa)
SA59 A A254G N85S
SA59 Bc  
S33R A  
S33G A A2350T T784S
S33G B A2511G S837S
S33G C  
T62S A  
T62A A  
L65H A T1626C 
C3074A A1025D
L65H B G857T S286I
L65H C  
L65A A G2500T D834Y
L65A B C3116T A1039V
L65A C  
L79M/T82M A  
L79M/T82M B  
L79M/T82M C  
L79A/T82A A C1010A A337D
L79A/T82A B  
Y162F A C939A 
K183R A T2874A 
K183G A  
K183G B  
K183G C  
() indicates no adventitious mutations.
a S gene sequences are numbered according to GenBank accession no.
AY497328.
b S genes of all recombinant viruses contained engineered mutations
introduced using targeted RNA recombination.
c Recombinant viruses indicated in bold were characterized further in
infection, neutralization and antibody blockade experiments.
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Most of the plaque-purified recombinant viruses released
between 2  106 and 2  107 PFU/ml into the tissue culture
medium by 48 h p.i., except for all three replicates of the
L79A/T82A virus that released only 1  103 PFU/ml, as
determined by plaque assay on 17 Cl 1 cell monolayers. To
determine whether aa substitutions in the RBD of S altered
the growth of MHV-A59 in murine cells, we examined the
plaque morphologies of the plaque-purified recombinant
viruses on 17 Cl 1 cell monolayers. When examined using
neutral red stained cells, the SA59, S33R, L79M/T82M,
Y162F and K183R viruses formed clear plaques like MHV-
A59, whereas the S33G, T62S, T62A and K183G viruses
formed turbid plaques (Fig. 4). The plaque-purified L65H
and L65A viruses formed opaque plaques that were difficult
to visualize with neutral red staining, but were readily
apparent using immunoperoxidase labeling of viral N
protein in 17 Cl 1 cell monolayers. Most of the recombinant
viruses formed large, 4–5 mm plaques at 72 h like MHV-
A59, whereas the three L79A/T82A viruses formed small,
2.9 mm plaques (Fig. 4). The plaque morphologies shared
by the three replicates of each mutant virus indicate that the
engineered mutations in S330 were responsible for the
observed phenotypes of these viruses.Interaction of recombinant viruses with murine CEACAM1a
Differences in plaque morphology could be caused by
alterations in receptor binding or membrane fusion activities
of mutant S proteins on virions. To investigate whether aa
substitutions in the RBD of S altered the susceptibility of
MHV-A59 virions to neutralization by soluble mCEA-
CAM1a, we incubated the SA59 B, S33R A, S33G C,
T62S A, T62A A, L65H C, L65A C, L79M/T82M A, Y162F
A, K183R A and K183G A viruses at neutral pH and 37 8C
with 70 nM of purified, anchorless mCEACAM1a[1,4]. This
concentration of mCEACAM1a[1,4] was 100-fold higher
than the ND50 for MHV-A59, but did not neutralize the
extended host range variant MHV/BHK (Schickli et al.,
1997; Zelus et al., 1998). Like MHV-A59, all of the
recombinant viruses were neutralized by mCEACAM1a[1,4]
at neutral pH and 37 8C (Fig. 5).The ability of soluble
mCEACAM1a to neutralize the L79A/T82A B virus was not
measured due to the low titer of this virus.
The neutralization of the mutant viruses by soluble
mCEACAM1a[1,4] at neutral pH and 37 8C suggested that
the soluble receptor bound to mutant S1 proteins on the
recombinant virions and induced a conformational change
in S2 like that observed for MHV-A59 (Gallagher, 1997;
Fig. 4. Plaque morphologies of recombinant viruses on murine 17 Cl 1 cell monolayers. Plaques of MHV-A59 or the plaque-purified recombinant viruses were
visualized at 72 h p.i. by neutral red staining (neutral red) or immunoperoxidase labeling of viral nucleocapsid protein (N antigen) in cell monolayers.
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further characterize the mCEACAM1a utilization of the
mutant viruses, we measured the yields of the SA59 B,
S33R A, S33G C, T62S A, T62A A, L65H C, L65A C,
L79M/T82M A, L79A/T82A B, Y162F A, K183R A and
K183G A viruses from 17 Cl 1 cells treated with anti-
mCEACAM1a MAb-CC1. MAb-CC1 binds to the N-
terminal domain of mCEACAM1a using an epitope that
overlaps, but is not identical to, the virus-binding site
(Dveksler et al., 1993a, 1993b; Wessner et al., 1998). Like
MHV-A59, none of the recombinant viruses infected 17 Cl
1 cells in the presence of MAb-CC1 (Fig. 6). Thus, aasubstitutions at S33, T62, L65, L79/T82, or K183 in S did
not prevent binding of MHV-A59 virions to soluble or
anchored mCEACAM1a.
Growth of recombinant viruses in non-murine cells
Since some of the aa substitutions in the RBD of S were
chosen to reflect residues found in S330 of related rat,
bovine or human coronaviruses in group II (Fig. 1A), we
examined the ability of the SA59 B, S33R A, S33G C, T62S
A, T62A A, L65H C, L65A C, L79M/T82M A, L79A/
T82A B, Y162FA, K183R A and K183G Aviruses to infect
Fig. 5. Neutralization of recombinant viruses with soluble, murine
CEACAM1a. MHV-A59 or the recombinant viruses (5000 PFU) were
pre-incubated with 70 nM of soluble mCEACAM1a[1,4]. Virus survival
was determined and percent neutralization calculated as described in
Materials and methods. Averages of percent neutralization F SEM of 2
independent experiments are shown.
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A59 infection. As determined by immunofluorescence
labeling of viral N protein and plaque formation, none of
the mutant viruses infected rat (RIE), human (HRT-18G) or
hamster (BHK) cells. RIE cells were susceptible to infection
by rat coronavirus (RCoV), HRT-18G cells were susceptible
to infection by bovine coronavirus and human coronavirus
strain OC43, while all three cell lines were susceptible to
infection by the extended host range variant MHV/BHK
(Schickli et al., 1997). In addition, viruses derived from the
Y162H, Y162Q and Y162A constructs did not infect RIE,
HRT-18 or BHK cell lines. Thus, aa substitutions at S33,
T62, L65, L79/T82, Y162 or K183 did not extend the host
range of MHV-A59.Fig. 6. Growth of recombinant viruses during anti-receptor antibody
blockade of murine 17 Cl 1 cells. Yields of MHV-A59 or the recombinant
viruses at 24 h p.i. from cells treated with 0.05 mg/ml of anti-CEACAM1a
MAb-CC1 or isotype matched MAb-Ctrl before, during and after
inoculation. The yield of the L79A/T82A B virus was assayed at 72 h
p.i. due the low titer of this virus. Virus yields shown are representative of
two independent experiments.Discussion
We used comparative analysis of S proteins from
coronaviruses in group II to identify residues in the receptor
binding domain, S330, that may be important for the
mCEACAM1a specificity of MHV virions. To study the
biological significance of aa substitutions in the RBD of S,
we used targeted RNA recombination (TRR) to generate
isogenic recombinant viruses that differ from MHV-A59 at
one or two residues in S330. Aa substitutions were selected
by identification of five residues, S33, L79, T82, Y162 and
K183, that are highly conserved in S330 of seven MHV
strains and the extended host range variant MHV/BHK, but
not in S330 of related group II coronaviruses of rats, cattle
and humans. Since MHV-A59 does not bind or infect rat,
bovine or human cell lines and RCoV does not bind to or
utilize mCEACAM1a (Compton et al., 1992; Gagneten et al.,
1996), we reasoned that these residues might be important for
the interactions of MHV-A59 with mCEACAM1a.In this study, we found that Y162 in the RBD of S is
critical for the recovery of MHV-A59 from cells expressing
mCEACAM1a. Fcwf cells inoculated with fMHV and
transfected with pMH54-EGFP or pMH54-EGFP RNAs
encoding Y162H, Y162Q, Y162A or Y162F substitutions
showed limited EGFP expression when plated alone (data
not shown). However, fMHV-inoculated Fcwf cells trans-
fected with pMH54-EGFP or pMH54-EGFP RNAs encod-
ing Y162H, Y162Q, Y162A or Y162F substitutions that
were overlaid onto 17 Cl 1 or BHK + mCEACAM1a(I41R)
cell monolayers showed increased CPE and EGFP expres-
sion (Fig. 2). These data strongly suggested that the majority
of CPE and EGFP expression observed was due to infection
of 17 Cl 1 or BHK + mCEACAM1a cells. Recombinant
viruses with Y162H and Y162Q substitutions inefficiently
infected 17 Cl 1 and BHK + mCEACAM1a(I41R) cell
monolayers (Fig. 2) and these viruses were not recovered
from either 17 Cl 1 or BHK + mCEACAM1a(I41R) cells
(Table 1). Although viruses with Y162A substitutions were
recovered from 17 Cl 1 and BHK + mCEACAM1a(I41R)
cells, the Y162A viruses formed minute plaques on 17 Cl 1
cell monolayers (Fig. 3) and had markedly lower yields than
MHV-A59. In contrast, F substitutions for Y162 were well
tolerated by the S proteins of MHV-A59, since the Y162F
viruses infected both 17 Cl 1 and mCEACAM1a(I41R) cells
as well as MHV-A59 (Figs. 2–4 and 6). These data suggest
that the phenyl ring of Y162 may form an essential
hydrophobic contact with the MHV-binding domain of
mCEACAM1a, and that this hydrophobic contact is
disrupted in S proteins with H, Q or A substitutions at
Y162. Alternatively, it is possible that H, Q or A
substitutions at Y162 may alter the local conformation or
stability of S proteins, since a S310G substitution in the S of
MHV-JHM is associated with decreased S1–S2 stability
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infectious bronchitis virus has been shown to inhibit
maturation and incorporation of S proteins into virions
(Shen et al., 2004). Additional studies will be needed to
determine whether Y162 participates directly in mCEA-
CAM1a binding, triggers the fusion activity of S and/or
maintains the conformation of the RBD of the MHV
S protein.
In this study, we found that viruses with S33R, L79A/
T82A or K183R substitutions in the RBD of S were readily
recovered from 17 Cl 1 cells. The S33R and K183R viruses
had wild-type growth in 17 Cl 1 cells, while the L79A/T82A
viruses formed small plaques on murine cell monolayers
(Fig. 4) and had reduced viral yields compared to MHV-A59.
Viruses with S33G, L79M/T82M or K183G substitutions in
S330 were never recovered from 17 Cl 1 cells. However,
these viruses could initially be recovered from BHK +
mCEACAM1a(I41R) cells that express 10-fold more recep-
tor than 17 Cl 1 cells or BHK cells stably expressing wild
type mCEACAM1a. The S33R, S33G, L79M/T82M, K183R
and K183G viruses were neutralized like MHV-A59 by
soluble mCEACAM1a at neutral pH and 37 8C (Fig. 5). In
addition, just like MHV-A59, the S33R, S33G, L79M/T82M,
L79A/T82A, K183R and K183G viruses bound mCEA-
CAM1a using an epitope that overlaps that of the blocking
anti-mCEACAM1a MAb-CC1 (Fig. 6). The recovery,
growth and plaque phenotypes shared by each independently
generated replicate of each mutant virus strongly suggests
that the engineered mutations in S330, rather than adventi-
tious mutations outside of the S gene, were responsible for
the observed phenotypes of these viruses.
The failure of the S33G, L79M/T82M and K183G viruses
to be recovered from 17 Cl 1 cells may have been due to
impaired interactions between mutant S proteins and
mCEACAM1a. During TRR, feline Fcwf cells infected with
fMHV and transfected with mutant MHV-A59 RNAs may
generate virions whose envelopes contain both chimeric
fMHV S proteins and mutant MHV-A59 S proteins due to
phenotypic mixing. The phenotypically heterogeneous
S33G, L79M/T82M and K183G virions may have impaired
interactions with mCEACAM1a. However, phenotypically
homogenous S33G, L79M/T82M and K183G virions,
generated in BHK + mCEACAM1a cells, may regain the
ability to interact with mCEACAM1a on 17 Cl 1 cells.
Alternatively, the high level of receptor expression on
BHK + mCEACAM1a(I41R) cells may facilitate the
recovery of these crippled viruses by increasing the number
of receptors available on cell membranes. In a similar
manner, increased expression of its cellular receptor partially
restores the infectivity of a Friend murine leukemia virus
with aa substitutions in its receptor binding pocket (Davey et
al., 1999). In addition, the I41R substitution in the N-
terminal domain of mCEACAM1a may facilitate the
recovery of crippled viruses with mutant S proteins.
Several residues in S330 that may be important for
binding to mCEACAM1a have previously been identified.A single T62S substitution or a triple T212S, Y214S,
Y216S substitution in soluble S330 of MHV-JHM reduced
binding to soluble mCEACAM1a in vitro (Suzuki and
Taguchi, 1996). Soluble receptor resistant (srr) mutants of
MHV-JHM with L65H substitutions in S330 also had
reduced binding to soluble mCEACAM1a in vitro (Saeki
et al., 1997). However, these srr mutants had wild-type
interactions with anchored mCEACAM1a expressed in
hamster cells (Matsuyama and Taguchi, 2000). In this study,
we found that isogenic recombinant MHV-A59 viruses with
T62S, T62A, L65H or L65A substitutions had wild-type
growth in 17 Cl 1 cells and were neutralized, like MHV-
A59, by soluble mCEACAM1a at neutral pH and 37 8C
(Figs. 5 and 6). The T62S and T62A viruses formed turbid
plaques on 17 Cl 1 cell monolayers, while the L65H and
L65A viruses formed opaque plaques (Fig. 4). Thus,
although T62 and L65 are not essential for mCEACAM1a
utilization by MHV-A59, these residues may nevertheless
influence spike-receptor interactions (Rao and Gallagher,
1998). We noted that T62 and L65 are conserved in S330 of
murine, rat, bovine and human coronaviruses in group II
(Fig. 1A). Since MHV-A59 does not bind rat, bovine or
human tissues or infect rat, bovine or human cell lines
(Compton et al., 1992), T62 and L65, individually, most
likely do not determine the receptor specificity of MHV.
In this study, we demonstrated that single aa substitutions
at S33, T62, L65, Y162 or K183 and double aa substitutions
at L79 and T82 in the RBD of S of MHV-A59 did not allow
the virus to interact with alternative receptors on murine or
non-murine cell lines. Like wild type MHV-A59, infection
of murine cells by viruses with substitutions at S33, T62,
L65, L79/T82, Y162 or K183 was blocked by anti-
mCEACAM1a MAb-CC1 (Fig. 6). None of the viruses
with substitutions at S33, T62, L65, L79/T82, Y162 or
K183 infected rat, hamster or human cell lines. Perhaps
multiple aa substitutions are needed to change the host range
of MHV-A59. We recently showed that 21 aa substitutions
and a 7-aa insert in the N-terminal region of S1 of MHV-
A59 are sufficient to extend the viral host range (Schickli et
al., 2004; Thackray and Holmes, 2004). Isogenic recombi-
nant viruses that differ from MHV-A59 by the 21 aa
substitutions and the 7-aa insert in S not only utilize
mCEACAM1a, but also as yet unidentified receptors on
murine and non-murine cells (Thackray and Holmes, 2004).
Alternatively, residues in the S proteins of rat, bovine and
human coronaviruses in group II critical for receptor binding
may not be found in S330. An aspartic acid at residue 454 in
the RBD of the distantly related SARS-CoV S protein is
essential for binding to ACE2 in vitro (Wong et al., 2004).
The mCEACAM1a-binding site in the MHV S glyco-
protein has previously been proposed to be conformation-
dependent based on the inhibition of MHV infection by
conformation-dependent anti-S MAbs (Suzuki and Taguchi,
1996). We postulate that Y162 may comprise part of a
hydrophobic pocket or patch in the RBD of S that interacts
with hydrophobic residues in the MHV-binding site of
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are known to play important roles in spike-receptor
interactions of other enveloped viruses such as herpes
simplex virus, human immunodeficiency virus and murine
retroviruses (Carfi et al., 2001; Connolly et al., 2003;
Kwong et al., 1998; Wu et al., 1996; Zhang et al., 2003).
Residues S33, T62, L65, L79, T82 and K183 are most likely
located peripheral to this hydrophobic binding site, since
binding hot spots in spike-receptor interactions are often
surrounded by energetically less critical residues, predom-
inantly charged in nature (Bogan and Thorn, 1998; Wang,
2002). Residues that extend the host range of MHV-A59
may also be located peripheral to the hydrophobic binding
site. During persistent MHV infection in murine cells, the
important mCEACAM1a binding residues in S are retained
(Baric et al., 1999; Schickli et al., 1997), while additional aa
substitutions may be selected that enhance the affinity or
avidity of S for mCEACAM1a and allow MHV to utilize as
yet unidentified alternative receptors on murine and non-
murine cells.Materials and methods
Antibodies
A mouse monoclonal antibody (MAb) to the MHV
nucleocapsid protein (N) (anti-N MAb) was provided by
Julian Leibowitz (Department of Pathology and Laboratory
Medicine, Texas A and M University, College Station, TX).
Mouse anti-mCEACAM1a MAb-CC1 blocks binding of
MHV to mCEACAM1a and infection of murine cells that
express mCEACAM1a, such as 17 Cl 1 cells (Dveksler et
al., 1993a, 1993b; Williams et al., 1990). A mouse MAb
directed against the h subunit of cholera toxin (MAb-Ctrl)
was used as an isotype matched control for anti-N MAb and
MAb-CC1.
Cell lines
The 17 Cl 1 cell line of spontaneously transformed
BALB/c 3T3 fibroblasts, rat intestinal epithelial (RIE) cells,
baby hamster kidney BHK-21 (BHK) cells, Felis catus
whole fetus (Fcwf) cells, Felis catus lung epithelial (AK-D)
cells and African green monkey kidney (Vero 76) cells were
propagated as previously described (Schickli et al., 1997;
Thackray and Holmes, 2004). Human rectal tumor clone G
cells (HRT-18G) were kindly provided by Johannes Storz
(Department of Veterinary Microbiology and Parasitology,
Louisiana State University School of Veterinary Medicine,
Baton Rouge, LO) and propagated in Dulbecco’s modified
Eagle medium (DMEM; GIBCO, Invitrogen Corporation,
Grand Island, NY) supplemented with 5% heat-inactivated
fetal bovine serum (FBS; Hyclone Laboratories, Inc.,
Logan, UT), 2% antibiotic-antimycotic (PSF; GIBCO) and
1.5 g/L sodium bicarbonate.To generate BHK cells stably transfected with a murine
CEACAM1a cDNA encoding an I41R substitution [BHK +
mCEACAM1a(I41R)], site-directed mutagenesis of mCEA-
CAM1a[1,4] in pCI-Neo (Invitrogen) was performed
with the mutagenic forward primer 5VCTACGGCTagaGAC-
AAAGAAATTG, and reverse primer 5VCAATTTCTTTG-
TCtctAGCCGTAG. BHK cells were transfected with cDNA
encoding the mCEACAM1a(I41R) or wild type mCEA-
CAM1a construct using Lipofectamine 2000 (Invitrogen), as
specified by the manufacturer, and selected using 500 Ag/ml
of Geneticin (GIBCO). Stably transfected BHK cells were
sorted twice on a Cytomation MoFlo cell sorter (Ft. Collins,
CO) for high levels of mCEACAM1a expression using anti-
CEACAM1a MAb-CC1 followed by phycoerythrin (PE)-
conjugated goat anti-mouse IgG (Jackson ImmunoResearch
Laboratories, Inc., West Grove, PA).
Viruses
MHV-A59 and fMHV were propagated in 17 Cl 1 and
Fcwf cells, respectively, as previously described (Kuo et al.,
2000; Schickli et al., 1997). Virus titers were measured by
plaque assay on 17 Cl 1, Fcwf, AK-D, RIE or BHK cells as
previously described (Gagneten et al., 1995; Kuo et al.,
2000). Virus-inoculated HRT-18G cells were incubated
under 0.8% SeaKem agarose (BioWhittaker Molecular
Applications, Rockland, ME) and MEM (GIBCO) with
8% FBS and 2% PSF.
Detection of virus-infected cells
Virus inoculation of cells grown on coverslips and
detection of newly synthesized viral nucleocapsid (N)
protein by immunofluorescence were performed as
previously described (Thackray and Holmes, 2004).
Virus-inoculated cell monolayers were incubated under
agar, and plaques were visualized by neutral red
staining or immunolabeling of viral N protein in cell
monolayers. Cell monolayers were washed with isotonic
phosphate buffered saline and fixed in methanol/acetic
acid at 20 8C for 10 min. Expression of N protein
was detected using anti-N MAb followed by biotiny-
lated anti-mouse IgG and avidin DH/biotinylated horse-
radish peroxidase (HRP) H complexes (VECTASTAIN
Elite ABC kit; Vector Laboratories Inc., Burlingame,
CA). Avidin–HRP complexes were visualized by depo-
sition of 3,3V-diaminobenzidine (DAB; Vector Laborato-
ries Inc., Burlingame, CA).
Alignment of S330 of Group II coronaviruses
S330 sequences of MHV strains and the corresponding
domains of other group II coronaviruses were obtained
using the following GenBank accession numbers: MHV-
A59 (AY497328), MHV-JHM (X04797), MHV-1
(D83333), MHV-2 (D83334), MHV-3 (D83335), MHV-S
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RCoV (AAF97738), BCoV strain L9 (P25191) and HCoV-
OC43 (Z21849). Deduced aa sequences were aligned and
five residues that were highly conserved in S330 of all
MHV strains, but not in S330 of other group II coronavi-
ruses were identified (Fig. 1A).
Generation of S constructs
The S constructs used in this paper were assembled in
pBC SK+ (Stratagene, La Jolla, CA) (Fig. 1B) and used to
replace the S gene of pMH54 (Kuo et al., 2000) or pMH54-
EGFP (Das Sarma et al., 2002). The transcription vector
pMH54-EGFP, containing the 3V-most 7.4 kb of the MHV-
A59 genome and the gene for enhanced green fluorescent
protein (EGFP) in place of gene 4, was kindly provided by
Susan Weiss (Department of Microbiology, University of
Pennsylvania School of Medicine, Philadelphia, PA). S gene
sequences in this paper were numbered according to
Genbank accession number AY497328 (Schickli et al.,
2004).
Site-directed mutagenesis was used to introduce point
mutations into a cDNA encoding the S protein, the S/pBC
SK+ construct containing an AvrII site at nt 37 (Thackray
and Holmes, 2004). Mutant S constructs were amplified
with cloned Pfu DNA polymerase (PFU; Stratagene, La
Jolla, CA) using various primer pairs (Table 3) essentially as
previously described (Wentworth and Holmes, 2001).
Mutant S constructs were screened by restriction enzyme
digestion and/or sequence analysis. All 14 S constructs were
subcloned into the S gene of pMH54 using AvrII and aTable 3
Oligonucleotides used for site directed mutagenesis and sequencing
Primer Sequence (5V–3V)a
Forward
K183G+ GCACACGGATGTAggACCCCCAATTTGTG
K183R+ GCACACGGATGTAAggCCCCCAATTTGTG
L65A+ GCCACATTATTGgcTACTGGTTACTACCCG
L65H+ GCCACATTATTGCaaACTGGTTACTACCCG
L79A/T82A+ GTTTAGAAACgcCGCTCTTgCGGGAACTAACTC
L79M/T82M+ GTTTAGAAACaTgGCTCTTAaGGGAACTAACTC
S33G+ GGTGCTAATGTTgGTGCTCCAAGCATTAGC
S33R+ GGTGCTAATGTTcGTGCTCCAAGCATTAGC
S(NotI)+ GCTGTTATAGcGGCCGcGTTTCTGCTGC
S(XbaI)+ GCTTAGGTGTTcTAGAAGATAATTGTGG
T62A+ CGAGTTTATTTAAATGCCgCtTTATTGCTTACTGG
T62S+ CGAGTTTATTTAAATGCCtCtTTATTGCTTACTGG
Y162A+ CCATTTGTCAGTTACCTgcCACTGATTGTAAGC
Y162F+ CCATTTGTCAGTTACCTTcaACTGATTGTAAGC
Y162H+ CCATTTGTCAGTTACCTcACACTGATTGTAAGC
Y162Q+ CCATTTGTCAGTTACCTcAaACTGATTGTAAGC
Reverse
572 TCGCTTTAACACACAAATTGG
BZ25 CCGTCTAGATATGTGGATCTTTTCAACGTC
a Nucleotides that differ from the S gene sequence of MHV-A59 (GenBank
accession no. AY497328) are shown in lower case. Nucleotides that encode
amino acid substitutions are underlined.DraIII site at nt 1271. Y162H, Q, A and F mutant S
constructs were also subcloned into pMH54-EGFP. The 5V
ends of each construct were sequenced by the University of
Colorado Cancer Center DNA Sequencing and Analysis
Core Facility using ABI Prism kits (Applied Biosystems,
Foster City, CA) as previously described (Wentworth and
Holmes, 2001). Six primers: Sstart, G133D-, A59.3, A59.4,
A59.30 and A59.22 (Schickli et al., 2004; Thackray and
Holmes, 2004) were used to generate overlapping sequences
for each construct.
Targeted RNA recombination
Mutations were introduced into the genome of MHV-
A59 by targeted RNA recombination (TRR) as previously
described (Thackray and Holmes, 2004). Briefly, Fcwf cells
were inoculated with the chimeric helper virus fMHV,
transfected with pMH54 or pMH54-EGFP derived donor
RNAs containing engineered mutations in the S gene, and
immediately overlaid onto 17 Cl 1 or BHK + mCEACA-
M1a(I41R) cell monolayers in individual 25-cm2 flasks.
After 48 h, culture media were collected, clarified by cen-
trifugation, and flash frozen. Independently recovered rep-
licates were plaque-purified and propagated in 17 Cl 1 cells.
Sequence analysis of recombinant viruses
Total cellular RNA from 17 Cl 1 cells inoculated with
each of the recombinant viruses was extracted and reverse
transcribed as previously described (Thackray and Holmes,
2004). The cDNA was amplified with primers Sstart and
A59.6 or A59.7 and 4a(IGS) as previously described
(Thackray and Holmes, 2004). Amplification products were
sequenced by the University of Colorado Cancer Center
DNA Sequencing and Analysis Core Facility as described
above. Eleven primers: 572, A59.3, A59.30, A59.C7,
S(XbaI)+, A59.20, S(NotI)+, A59.19, A59.10, A59.11,
and BZ25 [Table 3 and (Schickli et al., 2004; Thackray
and Holmes, 2004)] generated overlapping sequences for
each S gene.
Neutralization of viruses with purified, soluble murine
CEACAM1a protein
Virions were incubated with purified, anchorless mCEA-
CAM1a[1,4] essentially as described previously (Zelus et
al., 1998). Briefly, 30 Al of virus (5000 PFU) were incubated
with 180 Al of soluble mCEACAM1a diluted in Tris-
buffered saline with 5% glycerol (TBS-G) and 0.1 mg/ml
bovine serum albumin Fraction V (BSA) or TBS-G with 0.1
mg/ml BSA alone. After incubation for 1 h at 37 8C, virus
survival was determined by plaque assay on 17 Cl 1 cell
monolayers. Percent virus neutralization was calculated as:
100  [(number of plaques from virus incubated with
mCEACAM1a/number of plaques from virus incubated
with buffer alone)  100].
L.B. Thackray et al. / Virology 334 (2005) 98–110 109Receptor blockade with an anti-murine CEACAM1a
monoclonal antibody
Virus inoculation of murine cells in the presence of 0.05
mg/ml anti-CEACAM1a MAb-CC1 or isotype matched
MAb-Ctrl was performed as previously described (Schickli
et al., 1997; Thackray and Holmes, 2004).Acknowledgments
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